CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
locally advanced or metastatic disease.In addition, HER3-DXd will be evaluated in participants with locally advanced or metastatic NSCLC whose tumors...
Phase 1
Atlanta, Georgia, United States and 21 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Dunwoody, Georgia, United States and 123 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Atlanta, Georgia, United States and 210 other locations
The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...
Phase 2
Atlanta, Georgia, United States and 79 other locations
, early-stage non-small cell lung cancer....
Phase 2
Gainesville, Georgia, United States and 94 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Atlanta, Georgia, United States and 157 other locations
The primary objective of this study is to compare the efficacy of tarlatamab plus durvalumab with durvalumab alone on prolonging overall survival (OS...
Phase 3
Gainesville, Georgia, United States and 95 other locations
This phase I trial aims to determine if it is safe to use palliative radiotherapy and lurbinectedin at the same time to treat small cell lung...
Phase 1
Atlanta, Georgia, United States and 2 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...
Phase 2
Lawrenceville, Georgia, United States and 137 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Marietta, Georgia, United States and 182 other locations
Clinical trials
Research sites
Resources
Legal